Serial #76203218
DEAD

Serial Number

76203218

Owner

Diatos S.A.

Attorney

James R. Meyer

Filing Date

Jan 31, 2001

Add to watchlist:

No watchlists yet
View on USPTO

Serial #76203218 Trademark

Serial Number: 76203218 • Registration: 2708455

Serial #76203218 is a trademark filed by Diatos S.A. on January 31, 2001. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Diatos S.A. (3 trademarks)

166, Boulevard du Montparnasse
75014 Paris , FR

Entity Type: 16

Trademark Details

Filing Date

January 31, 2001

Registration Date

April 22, 2003

Published for Opposition

January 28, 2003

Cancellation Date

November 28, 2009

Goods & Services

Pharmaceutical preparations for the treatment of viral, bacterial, fungal and parasitic infections; cancer; degenerative diseases; metabolic and endocrine diseases; cardiovascular diseases; inflammatory diseases; autoimmune diseases; and dermatological diseases; veterinary vaccines for small, large and exotic animals; chemopharmaceutical preparations for use in chemotherapy; media for bacteriological and bacterial cultures for medical and veterinary use; diagnostic preparations for clinical or medical laboratory use

Chemical, biochemical, biological, biotechnological products and preparations, namely nucleic acids, proteins, antibiotics, antiviral molecules and immunomodulators, intended for the pharmaceutical industry and for the sciences, other than for medical or veterinary use; chemical, biochemical, biological, biotechnological products, namely nucleic acids, proteins, antibiotics, antiviral molecules and immunomodulators for laboratory analyses, other than for medical or veterinary use; biochemicals namely, precursors for in vitro genetic engineering use; diagnostic preparations for scientific or research use, namely, cell lines, diagnosis kits, comprised of cell penetrating peptides conjugated to antibodies against intracellular and intranuclear markers or antigens; labeling kits, comprised of cell penetrating peptides tagged with markers for intracellular and intranuclear labeling of targets; expression kits, comprised of cell penetrating peptides acting as transfection or gene transfer agents; development kits, comprised of cell penetrating peptides for intracellular and intranuclear delivery of drug candidates for drug screening purposes; and target validation kits comprised of cell penetrating peptides coupled with drug candidates or markers for intracellular and intranuclear target validation; chemical reagents for scientific or research use

Technical consultation and research in biology, in plant and animal biotechnology, pharmacology, biology, biotechnology, pharmacy, and medicine; providing information in the fields of biology, biotechnology, pharmacy, and medicine; research and development of new products for others in the fields of pharmacy, biology and biotechnology, medicine and the sciences; laboratory research in the fields of biology, biotechnology, pharmacy, and medicine and the sciences; genetic engineering in the fields of pharmacology, medicine, the sciences

Filing History

CANCELLED SEC. 8 (6-YR)
Nov 28, 2009 C8..
CASE FILE IN TICRS
Mar 5, 2008 CFIT
REGISTERED-PRINCIPAL REGISTER
Apr 22, 2003 R.PR
PUBLISHED FOR OPPOSITION
Jan 28, 2003 PUBO
NOTICE OF PUBLICATION
Jan 8, 2003 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 27, 2002 CNSA
EXAMINERS AMENDMENT MAILED
Nov 27, 2002 CNEA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 8, 2002 CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 30, 2002 CRFA
NON-FINAL ACTION MAILED
Mar 5, 2002 CNRT
ASSIGNED TO EXAMINER
Feb 27, 2002 DOCK
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 13, 2001 CRFA
NON-FINAL ACTION MAILED
May 21, 2001 CNRT
ASSIGNED TO EXAMINER
May 16, 2001 DOCK